A prospective, randomized, double-blind, placebo-controlled parallel-group dual site trial to evaluate the effects of a Bacillus coagulans-based product on functional intestinal gas symptoms
about
Gut microbiota role in irritable bowel syndrome: New therapeutic strategiesProbiotic Bacillus coagulans GBI-30, 6086 reduces exercise-induced muscle damage and increases recovery.Review article: the treatment of functional abdominal bloating and distension.Lactobacillus johnsonii N6.2 Modulates the Host Immune Responses: A Double-Blind, Randomized Trial in Healthy Adults.The overarching influence of the gut microbiome on end-organ function: the role of live probiotic cultures.Systematic review: probiotics in the management of lower gastrointestinal symptoms in clinical practice -- an evidence-based international guide.Probiotic vs. Placebo in Irritable Bowel Syndrome:A Randomized Controlled Trial.Spore-forming bacteria and their utilisation as probiotics.The effects of probiotic, prebiotic and synbiotic diets containing Bacillus coagulans and inulin on rat intestinal microbiota.Draft Genome Sequence of Bacillus coagulans GBI-30, 6086, a Widely Used Spore-Forming Probiotic Strain.Probiotic Bacillus coagulans GBI-30, 6086 Improves Protein Absorption and Utilization.Transcriptional regulation of adhesive properties of Bacillus subtilis to extracellular matrix proteins through the fibronectin-binding protein YloA.Systematic review: probiotics in the management of lower gastrointestinal symptoms - an updated evidence-based international consensus.Effects of Bacillus coagulans supplementation on the growth performance and gut health of broiler chickens with Clostridium perfringens-induced necrotic enteritis.Integrate genome-based assessment of safety for probiotic strains: Bacillus coagulans GBI-30, 6086 as a case study.Potential Use of Bacillus coagulans in the Food Industry.Bacillus coagulans GBI-30, 6086 Modulates Faecalibacterium prausnitzii in Older Men and Women
P2860
Q26768550-81D5E80D-2ED1-4E77-8379-C9EB9887A0C5Q30376209-4FCD2E16-2896-4CD3-A292-6A16F231835EQ33450132-9887FB22-A2E0-4A98-B3AA-5375B9BFCA03Q33785703-8CA6918D-8E56-4DD2-BEFD-C34AE4833E36Q34309689-D36E9CB7-8353-4302-A18D-2078D3B16A34Q37587557-743827FC-B66A-4F9D-B5B4-654C19BD349FQ37708341-C8C331F5-E32A-4903-B2A6-088633BFAD0EQ37986269-FAED9039-8603-4358-B700-B15A04AABBC3Q38841645-BD502BDC-BC01-4899-B551-3B04C28C7334Q42983586-8CB64361-7D24-4809-B7A9-6C9AFD6C6EFFQ47339591-10A1D76B-8869-49B7-A587-2A134D7F1616Q48127523-89EE780D-50DD-4668-957C-FCE723B833F1Q49822026-23ED40BA-AD98-4F9A-8B30-5AB457EDDBA4Q49916765-F4EBC438-6B82-4F1A-A99B-2C3004BE0515Q53794169-F7763BCC-3111-4B5C-84EC-09CB736C266CQ55465131-936EC052-3F5F-4ADC-8164-6F9A9B00A4E4Q58476456-A458C29F-9D44-4A78-8A1C-7984B12FC572
P2860
A prospective, randomized, double-blind, placebo-controlled parallel-group dual site trial to evaluate the effects of a Bacillus coagulans-based product on functional intestinal gas symptoms
description
2009 nî lūn-bûn
@nan
2009 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
2009 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
2009年の論文
@ja
2009年論文
@yue
2009年論文
@zh-hant
2009年論文
@zh-hk
2009年論文
@zh-mo
2009年論文
@zh-tw
2009年论文
@wuu
name
A prospective, randomized, dou ...... tional intestinal gas symptoms
@ast
A prospective, randomized, dou ...... tional intestinal gas symptoms
@en
type
label
A prospective, randomized, dou ...... tional intestinal gas symptoms
@ast
A prospective, randomized, dou ...... tional intestinal gas symptoms
@en
prefLabel
A prospective, randomized, dou ...... tional intestinal gas symptoms
@ast
A prospective, randomized, dou ...... tional intestinal gas symptoms
@en
P2093
P2860
P356
P1433
P1476
A prospective, randomized, dou ...... tional intestinal gas symptoms
@en
P2093
Diane R Krieger
Douglas S Kalman
Howard I Schwartz
John C Pezzullo
Patricia Alvarez
Samantha Feldman
P2860
P2888
P356
10.1186/1471-230X-9-85
P577
2009-11-18T00:00:00Z
P6179
1026536772